POC検査機器の世界市場:血糖検査、感染症検査、心疾患マーカー検査、凝固検査、妊娠検査、血液ガス検査、腫瘍マーカー検査、尿検査、コレステロール検査

◆英語タイトル:Global POC Diagnostics Market 2015-2019
◆商品コード:IRTNTR5374
◆発行会社(調査会社):Technavio
◆発行日:2015年2月25日
◆ページ数:104
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Five UserUSD3,500 ⇒換算¥388,500見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,500 ⇒換算¥499,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、POC検査機器の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、POC検査機器の世界市場規模及び予測、用途別分析、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About POC Diagnostics
POC diagnostics are IVD devices and tools used for diagnosing diseases in patients outside a clinical laboratory setting. The use of these devices helps in the rapid diagnosis of the medical conditions and aids in providing appropriate treatments and medication to patients. They are cost-effective, user-friendly, and standardized to minimize errors during diagnosis. They are being used extensively for diagnostic purposes owing to the high prevalence of lifestyle diseases such as diabetes and obesity, cardiac disorders, and infectious diseases. They have a wide range of applications in clinical diagnosis such as the testing of blood glucose and coagulation, infectious diseases, cardiac markers, pregnancy and fertility, blood gas/electrolytes, tumor markers, urinalysis, and cholesterol.

TechNavio’s analysts forecast the Global POC Diagnostics market to grow at a CAGR of 8.47 percent over the period 2014-2019.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global POC Diagnostics market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of POC diagnostics used in various applications:
• Blood glucose testing
• Infectious diseases testing
• Cardiac markers testing
• Coagulation testing
• Pregnancy and fertility testing
• Blood gas/electrolytes testing
• Tumor markers testing
• Urinalysis testing
• Cholesterol testing

TechNavio’s report, the Global POC Diagnostics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global POC Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott Laboratories
• Alere
• Bayer Healthcare
• Danaher
• F. Hoffmann-La Roche
• Johnson & Johnson

[Other Prominent Vendors]
• A. Menarini Diagnostics
• Abaxis
• Acon
• BD
• Bio-Rad Laboratories
• Chembio Diagnostics
• Chongqing Haray International Business
• Clarity Diagnostics
• Clinical Innovations
• Contec Medical
• Eurotrol
• Fudakang Ind’l
• Helena Laboratories
• i-sens
• International Technidyne
• Medtronic
• Nipro Diagnostics
• Nova Biomedical
• OraSure Technologies
• Phamatech
• Quidel
• Radiometer Medical
• Randox Laboratories
• SA Scientific
• Sekisui Diagnostics
• Shenzhen Fitconn Technology
• Siemens Healthcare
• STAT Technologies
• Streck
• TaiDoc
• Trinity Biotech
• Urit Medical

[Market Driver]
• High Prevalence of Diabetes and Obesity
• For a full, detailed list, view our report

[Market Challenge]
• Limitation of POC Diagnostics
• For a full, detailed list, view our report

[Market Trend]
• Rapid Adoption of POC Diagnostic Tests
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 POC Diagnostics Market in US
06.3.1 Market Size and Forecast
06.4 POC Diagnostics Market in Europe
06.4.1 Market Size and Forecast
06.5 Five Forces Analysis

07.Market Segmentation by Application
07.1 Global Blood Glucose Testing Market
07.1.1 Market Size and Forecast
07.2 Global Infectious Diseases Testing Market
07.2.1 Market Size and Forecast
07.3 Global Cardiac Markers Testing Market
07.3.1 Market Size and Forecast
07.4 Global Coagulation Testing Market
07.4.1 Market Size and Forecast
07.5 Global Pregnancy and Fertility Testing Market
07.5.1 Market Size and Forecast
07.6 Global Blood Gas/Electrolytes Testing Market
07.6.1 Market Size and Forecast
07.7 Global Tumor Markers Testing Market
07.7.1 Market Size and Forecast
07.8 Global Urinalysis Testing Market
07.8.1 Market Size and Forecast
07.9 Global Cholesterol Testing Market
07.9.1 Market Size and Forecast

08.Geographical Segmentation
08.1 POC Diagnostics Market in Americas
08.1.1 Market Size and Forecast
08.2 POC Diagnostics Market in EMEA Region
08.2.1 Market Size and Forecast
08.3 POC Diagnostics Market in APAC Region
08.3.1 Market Size and Forecast

09.Buying Criteria

10.Market Growth Drivers

11.Drivers and their Impact

12.Market Challenges

13.Impact of Drivers and Challenges

14.Market Trends

15.Trends and their Impact

16.Vendor Landscape
16.1 Competitive Scenario
16.1.1 Key News
16.1.2 Mergers and Acquisitions
16.2 Vendor Analysis 2014
16.3 Other Prominent Vendors

17.Key Vendor Analysis
17.1 Abbott Laboratories
17.1.1 Key Facts
17.1.2 Business Overview
17.1.3 Business Segmentation by Revenue
17.1.4 Business Segmentation by Revenue 2011 and 2012
17.1.5 Geographical Segmentation by Revenue
17.1.6 Business Strategy
17.1.7 Key Information
17.1.8 SWOT Analysis
17.2 Alere
17.2.1 Key Facts
17.2.2 Business Overview
17.2.3 Business Segmentation by Revenue 2013
17.2.4 Business Segmentation by Revenue 2012 and 2013
17.2.5 Geographical Segmentation by Revenue 2013
17.2.6 Business Strategy
17.2.7 Recent Developments
17.2.8 SWOT Analysis
17.3 Bayer HealthCare
17.3.1 Key Facts
17.3.2 Business Overview
17.3.3 Business Segmentation by Revenue 2013
17.3.4 Business Segmentation by Revenue 2012 and 2013
17.3.5 Geographical Segmentation by Revenue 2013
17.3.6 Business Strategy
17.3.7 Recent Developments
17.3.8 SWOT Analysis
17.4 Danaher
17.4.1 Key Facts
17.4.2 Business Overview
17.4.3 Business Segmentation
17.4.4 Revenue by Business Segmentation
17.4.5 Revenue Comparison 2012 and 2013
17.4.6 Segmentation by Geography
17.4.7 Business Strategy
17.4.8 Key Information
17.4.9 SWOT Analysis
17.5 F. Hoffmann-La Roche
17.5.1 Key Facts
17.5.2 Business Overview
17.5.3 Business Segmentation
17.5.4 Geographical Segmentation by Revenue 2013
17.5.5 Business Strategy
17.5.6 Key Information
17.5.7 SWOT Analysis
17.6 Johnson & Johnson
17.6.1 Key Facts
17.6.2 Business Overview
17.6.3 Business Segmentation by Revenue 2013
17.6.4 Business Segmentation by Revenue 2012 and 2013
17.6.5 Geographical Segmentation by Revenue 2013
17.6.6 Business Strategy
17.6.7 Recent Developments
17.6.8 SWOT Analysis

18.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global POC Diagnostics Market 2014-2019 (US$ million)
Exhibit 3: POC Diagnostics Market in US 2014-2019 (US$ million)
Exhibit 4: POC Diagnostics Market in Europe 2014-2019 (US$ million)
Exhibit 5: Segmentation of Global POC Diagnostics Market by Application
Exhibit 6: Global POC Diagnostics Market by Application 2014
Exhibit 7: Global Blood Glucose Testing Market 2014-2019 (US$ million)
Exhibit 8: Global Infectious Diseases Testing Market 2014-2019 (US$ million)
Exhibit 9: Global Cardiac Markers Testing Market 2014-2019 (US$ million)
Exhibit 10: Global Coagulation Testing Market 2014-2019 (US$ million)
Exhibit 11: Global Pregnancy and Fertility Testing Market 2014-2019 (US$ million)
Exhibit 12: Global Blood Gas/Electrolytes Testing Market 2014-2019 (US$ million)
Exhibit 13: Global Tumor Markers Testing Market 2014-2019 (US$ million)
Exhibit 14: Global Urinalysis Testing Market 2014-2019 (US$ million)
Exhibit 15: Global Cholesterol Testing Market 2014-2019 (US$ million)
Exhibit 16: Segmentation of Global POC Diagnostics Market by Application 2014-2019 (US$ million)
Exhibit 17: Segmentation of Global POC Diagnostics Market by Application 2014-2019
Exhibit 18: Geographical Segmentation of Global POC Diagnostics Market 2014
Exhibit 19: POC Diagnostics Market in Americas 2014-2019 (US$ million)
Exhibit 20: POC Diagnostics Market in EMEA Region 2014-2019 (US$ million)
Exhibit 21: POC Diagnostics Market in APAC Region 2014-2019 (US$ million)
Exhibit 22: Geographical Segmentation of Global POC Diagnostics Market 2014-2019 (US$ million)
Exhibit 23: Geographical Segmentation of Global POC Diagnostics Market 2014-2019
Exhibit 24: Abbott Laboratories: Business Segmentation by Revenue 2012
Exhibit 25: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
Exhibit 26: Abbott Laboratories: Geographical Segmentation by Revenue 2012
Exhibit 27: Global POC Diagnostics Market: Business Segmentation by Revenue 2013
Exhibit 28: Global POC Diagnostics Market: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 29: Global POC Diagnostics Market: Geographical Segmentation by Revenue 2013
Exhibit 30: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 31: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 33: Danaher: Business Segmentation
Exhibit 34: Danaher: Business Segmentation 2013
Exhibit 35: Danaher: Revenue by Business Segmentation 2012 and 2013 (US$ million)
Exhibit 36: Danaher: Revenue by Geographical Segmentation 2013
Exhibit 37: F. Hoffmann-La Roche: Business Segmentation 2013
Exhibit 38: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 39: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals)
Exhibit 40: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics)
Exhibit 41: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 42: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 43: Johnson & Johnson: Geographical Segmentation by Revenue 2013



【掲載企業】

Abbott Laboratories, Alere , Bayer Healthcare, Danaher, F. Hoffmann-La Roche, Johnson & Johnson, A. Menarini Diagnostics , Abaxis, Acon, BD , Bio-Rad Laboratories, Chembio Diagnostics , Chongqing Haray International Business, Clarity Diagnostics,Clinical Innovations, Contec Medical , Eurotrol, Fudakang Ind'l, Helena Laboratories, i-sens, International Technidyne, Medtronic, Nipro Diagnostics, Nova Biomedical, OraSure Technologies, Phamatech , Quidel , Radiometer Medical, RandoxLaboratories , SA Scientific, Sekisui Diagnostics, Shenzhen Fitconn Technology, Siemens Healthcare, STAT Technologies, Streck, TaiDoc, Trinity Biotech, Urit Medical

【レポートのキーワード】

POC検査機器、POC診断、血糖検査、感染症検査、心疾患マーカー検査、凝固検査、妊娠検査、血液ガス検査、腫瘍マーカー検査、尿検査、コレステロール検査、医療装置

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[POC検査機器の世界市場:血糖検査、感染症検査、心疾患マーカー検査、凝固検査、妊娠検査、血液ガス検査、腫瘍マーカー検査、尿検査、コレステロール検査] (コード:IRTNTR5374)販売に関する免責事項を必ずご確認ください。
★調査レポート[POC検査機器の世界市場:血糖検査、感染症検査、心疾患マーカー検査、凝固検査、妊娠検査、血液ガス検査、腫瘍マーカー検査、尿検査、コレステロール検査]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆